Patent Issued for Spray ejector mechanisms and devices providing charge isolation and controllable droplet charge, and low dosage volume ophthalmic administration (USPTO 12029682).

A patent has been issued to Eyenovia Inc. for spray ejector mechanisms and devices that provide charge isolation and controllable droplet charge, as well as low dosage volume ophthalmic administration. The invention aims to address the challenges of consistent and accurate delivery of eye medications, particularly for individuals who have difficulty administering eye drops. The patent describes methods for delivering low dosage volume medicament compositions to the eye by controlling droplet charge, size, and deposit parameters. The invention offers a safe and reproducible alternative to standard eyedropper use and dosage volumes. [Extracted from the article]

Copyright of Pharma Business Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)